Landscape Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,607
Closed -$908K 766
2026
Q1
$908K Sell
17,607
-4,248
-19% -$297K 0.06% 408
2025
Q4
$2.02M Buy
21,855
+3,567
+20% +$341K 0.14% 227
2025
Q3
$1.36M Buy
18,288
+13,305
+267% +$1.35M 0.09% 311
2025
Q2
$647K Sell
4,983
-2,676
-35% -$388K 0.05% 409
2025
Q1
$1.22M Buy
+7,659
New +$1.39M 0.11% 267
2022
Q4
Sell
-11,715
Closed -$2.08M 895
2022
Q3
$2.08M Sell
11,715
-628
-5% -$126K 0.27% 73
2022
Q2
$2.25M Buy
12,343
+380
+3% +$75.8K 0.3% 68
2022
Q1
$3.07M Sell
11,963
-327
-3% -$74.7K 0.39% 62
2021
Q4
$2.83M Sell
12,290
-103
-0.8% -$25.1K 0.4% 64
2021
Q3
$2.89M Sell
12,393
-1,833
-13% -$382K 0.4% 61
2021
Q2
$2.75M Buy
14,226
+784
+6% +$155K 0.34% 81
2021
Q1
$2.78M Buy
+13,442
New +$2.86M 0.44% 57
2020
Q4
Sell
-8,969
Closed -$1.16M 389
2020
Q3
$1.16M Buy
+8,969
New +$988K 0.21% 95

Other funds holding INSP

Landscape Capital Management's INSP Position: Q2 2026 in Review

Landscape Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 17,607 shares — an estimated $908K sold.

Landscape Capital Management first reported a position in INSP in Q3 2020 and held it in 13 quarters. The position peaked at $3.07M in Q1 2022. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Landscape Capital Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 17,607 Inspire Medical Systems shares in Q2 2026, an estimated $908K.
  • Landscape Capital Management first reported a position in Inspire Medical Systems in Q3 2020 and held it in 13 quarters.
  • Landscape Capital Management's Inspire Medical Systems position peaked at $3.07M in Q1 2022.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.